Macrophage cholesterol efflux and the active domains of serum amyloid A 2.1

被引:43
作者
Kisilevsky, R [1 ]
Tam, SP
机构
[1] Queens Univ, Dept Pathol, Kingston, ON K7L 3N6, Canada
[2] Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada
[3] Syl & Molly Apps Res Ctr, Kingston, ON K7L 3N6, Canada
[4] Kingston Gen Hosp, Kingston, ON K7L 3N6, Canada
关键词
acyl-CoA : cholesterol acyltransferase macrophages; in vivo;
D O I
10.1194/jlr.M300133-JLR200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Serum amyloid A 2.1 (SAA2.1) suppresses ACAT and stimulates cholesteryl ester hydrolase (CEH) activities in cholesterol-laden macrophages, and in the presence of a cholesterol transporter and an extracellular acceptor, there is a marked increase in the rate of cholesterol export in culture and in vivo. The stimulation of CEH activity by SAA2.1 is not affected by chloroquine, suggesting that it operates on neutral CEH rather than the lysosomal form. With liposomes containing individual peptides of SAA2.1, residues 1-20 inhibit ACAT activity, residues 74-103 stimulate CEH activity, and each of residues 1-20 and 74-103 promotes macrophage cholesterol efflux to HDL in culture media. In combination, these peptides exhibit a profound effect, so that 55-70% of cholesterol is exported to media HDL in 24 h. The effect is also demonstrable in vivo. [H-3]cholesterol-laden macrophages injected intravenously into mice were allowed to establish themselves for 24 h. Thereafter, the mice received a single intravenous injection of liposomes containing intact SAA1.1, SAA2.1, peptides composed of SAA2.1 residues 1-20, 21-50, 51-80, 74-103, or SAA1.1 residues 1-20. Only liposomes containing intact SAA2.1 or its residues 1-20 or 74-103 promoted the efflux of cholesterol in vivo. A single injection of each of the active peptides is effective in promoting cholesterol efflux in vivo for at least 4 days.
引用
收藏
页码:2257 / 2269
页数:13
相关论文
共 60 条
[1]  
ALLAIN CC, 1974, CLIN CHEM, V20, P470
[2]   The heparin heparan sulfate-binding site on apo serum amyloid A - Implications for the therapeutic intervention of amyloidosis [J].
Ancsin, JB ;
Kisilevsky, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (11) :7172-7181
[3]   Laminin interactions with the apoproteins of acute-phase HDL: preliminary mapping of the laminin binding site on serum amyloid A [J].
Ancsin, JB ;
Kisilevsky, R .
AMYLOID-INTERNATIONAL JOURNAL OF EXPERIMENTAL AND CLINICAL INVESTIGATION, 1999, 6 (01) :37-47
[4]   TIME COURSE OF SERUM AMYLOID-A RESPONSE IN MYOCARDIAL-INFARCTION [J].
BAUSSERMAN, LL ;
SADANIANTZ, A ;
SARITELLI, AL ;
MARTIN, VL ;
NUGENT, AM ;
SADY, SP ;
HERBERT, PN .
CLINICA CHIMICA ACTA, 1989, 184 (03) :297-306
[5]   EXPRESSION OF THE 3RD MEMBER OF THE SERUM AMYLOID A GENE FAMILY IN MOUSE ADIPOCYTES [J].
BENDITT, EP ;
MEEK, RL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 169 (05) :1841-1846
[6]   Statins: Effective antiatherosclerotic therapy [J].
Blumenthal, RS .
AMERICAN HEART JOURNAL, 2000, 139 (04) :577-583
[7]   Roles of acyl-coenzyme A:cholesterol acyltransferase-1 and-2 [J].
Chang, TY ;
Chang, CCY ;
Lin, S ;
Yu, CJ ;
Li, BL ;
Miyazaki, A .
CURRENT OPINION IN LIPIDOLOGY, 2001, 12 (03) :289-296
[8]  
CLIFTON PM, 1985, J LIPID RES, V26, P1389
[9]   INFLUENCE OF INCREASED MEMBRANE CHOLESTEROL ON MEMBRANE FLUIDITY AND CELL-FUNCTION IN HUMAN RED BLOOD-CELLS [J].
COOPER, RA .
JOURNAL OF SUPRAMOLECULAR STRUCTURE, 1978, 8 (04) :413-430
[10]  
DEBEER MC, 1995, J LIPID RES, V36, P526